Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Rumzhum, NN"'
© 2018 Wiley Periodicals, Inc. Prostaglandin E 2 (PGE 2 ) is a key prostanoid known to have both proinflammatory and anti-inflammatory impact in the context of chronic respiratory diseases. We hypothesize that these opposing effects may be the resul
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______363::7ce21defb3087e021d766baeb079b806
https://hdl.handle.net/10453/129046
https://hdl.handle.net/10453/129046
© 2018 Elsevier Ltd Arachidonic acid is metabolized by cyclooxygenases (COX-1 and COX-2) into various prostanoids which exert different functions in mammalian physiology. One of these prostanoids, prostaglandin E 2 (PGE 2 ), interacts with four diff
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______363::22238b88322af15ca2613b05b7790aeb
https://hdl.handle.net/10453/122339
https://hdl.handle.net/10453/122339
Autor:
Rumzhum, NN, Ammit, AJ
©2016 Published by Elsevier B.V. Prostaglandin E2 (PGE2) is a prostanoid with diverse actions in health and disease. In chronic respiratory diseases driven by inflammation, PGE2 has both positive and negative effects. An enhanced understanding of th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______363::0e3c3a3427684b7cb8b6dfeed7a97c95
https://hdl.handle.net/10453/128759
https://hdl.handle.net/10453/128759
© 2015 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd. Background IL-17A plays an important role in respiratory disease and is a known regulator of pulmonary inflammation and immunity. Recent studies have linked IL-17A with exacerbation i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______363::50e379df58cff61578e83c7769ac3957
https://hdl.handle.net/10453/41773
https://hdl.handle.net/10453/41773
Copyright © 2016 by the American Thoracic Society. Tachyphylaxis of the β2-adrenergic receptor limits the efficacy of bronchodilatory β2-agonists in respiratory disease. Cellular studies in airway smooth muscle (ASM) have shown that inflammatory m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______363::d3dfdfecf2e0d289624f1a612585b61e
https://hdl.handle.net/10453/41775
https://hdl.handle.net/10453/41775
Autor:
Alkhouri, H, Rumzhum, NN, Rahman, MM, Fitzpatrick, M, De Pedro, M, Oliver, BG, Bourke, JE, Ammit, AJ
Background Asthma is a widespread chronic health problem exacerbated by common viral and bacterial infections. Further research is required to understand how infection worsens asthma control in order to advance therapeutic options in the future. Rece
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______363::2e44573a9e8f023d167b671ab0b9388d
https://hdl.handle.net/10453/115527
https://hdl.handle.net/10453/115527
Mitogen-activated protein kinase phosphatase 1 (MKP-1) represses MAPK-driven signalling and plays an important anti-inflammatory role in asthma and airway remodelling. Although MKP-1 is corticosteroid-responsive and increased by cAMP-mediated signall
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______363::cce4e51ebdda3a672af4d3b92918a6c8
https://hdl.handle.net/10453/116746
https://hdl.handle.net/10453/116746
Autor:
Bradbury P; Woolcock Emphysema Centre, Woolcock Institute of Medical Research, University of Sydney, Sydney, New South Wales, Australia.; School of Life Sciences, Faculty of Science, University of Technology Sydney, Sydney, New South Wales, Australia., Rumzhum NN; Faculty of Pharmacy, University of Sydney, Sydney, New South Wales, Australia., Ammit AJ; Woolcock Emphysema Centre, Woolcock Institute of Medical Research, University of Sydney, Sydney, New South Wales, Australia.; School of Life Sciences, Faculty of Science, University of Technology Sydney, Sydney, New South Wales, Australia.
Publikováno v:
Journal of cellular physiology [J Cell Physiol] 2019 Jul; Vol. 234 (7), pp. 11070-11077. Date of Electronic Publication: 2018 Dec 07.
Autor:
Lebender LF; Faculty of Pharmacy, University of Sydney, NSW, Australia., Prünte L; Faculty of Pharmacy, University of Sydney, NSW, Australia., Rumzhum NN; Faculty of Pharmacy, University of Sydney, NSW, Australia., Ammit AJ; School of Life Sciences, University of Technology Sydney, NSW, Australia; Woolcock Emphysema Centre, Woolcock Institute of Medical Research, University of Sydney, NSW, Australia. Electronic address: Alaina.Ammit@uts.edu.au.
Publikováno v:
Pulmonary pharmacology & therapeutics [Pulm Pharmacol Ther] 2018 Apr; Vol. 49, pp. 75-87. Date of Electronic Publication: 2018 Jan 31.
Autor:
Rahman MM; Faculty of Pharmacy, University of Sydney, NSW, Australia., Prabhala P; Faculty of Pharmacy, University of Sydney, NSW, Australia., Rumzhum NN; Faculty of Pharmacy, University of Sydney, NSW, Australia., Patel BS; Faculty of Pharmacy, University of Sydney, NSW, Australia., Wickop T; Faculty of Pharmacy, University of Sydney, NSW, Australia., Hansbro PM; Priority Research Centre for Respiratory Diseases, Hunter Medical Research Institute and The University of Newcastle, Newcastle, Australia., Verrills NM; School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, University of Newcastle, NSW, Australia., Ammit AJ; Woolcock Emphysema Centre, Woolcock Institute of Medical Research, University of Sydney, NSW, Australia; School of Life Sciences, Faculty of Science, University of Technology Sydney, NSW, Australia. Electronic address: Alaina.Ammit@uts.edu.au.
Publikováno v:
The international journal of biochemistry & cell biology [Int J Biochem Cell Biol] 2016 Sep; Vol. 78, pp. 279-287. Date of Electronic Publication: 2016 Jul 28.